Skip to main content
Premium Trial:

Request an Annual Quote

Akoya Biosciences: Marilee Moy

Akoya Biosciences has appointed Marilee Moy as its chief people officer. Prior to joining Akoya, Moy led human resources at Talis Biomedical after serving as VP of people at Counsyl, now part of Myriad Genetics. She has also held various HR leadership roles at Genentech, Abbott, Johnson & Johnson, and Nikon Precision. Moy holds a BA from Boston College and an MBA from Golden Gate University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.